Related Experiment Videos
Malignant infarction in cats after prolonged middle cerebral artery occlusion: glutamate elevation related to
Shingo Toyota1, Rudolf Graf, Mario Valentino
1Max-Planck Institut für neurologische Forschung, Köln, Germany.
Stroke
|May 4, 2002
Summary
Elevated glutamate during ischemic stroke predicts fatal outcomes. Secondary glutamate surges during reperfusion, linked to decreased cerebral perfusion pressure, indicate severe brain injury.
Area of Science:
- Neuroscience
- Cerebrovascular Research
- Biochemistry
Background:
- Investigating glutamate's role in ischemic stroke is crucial for understanding secondary deterioration.
- Space-occupying ischemic stroke models are vital for studying outcomes after reperfusion.
Purpose of the Study:
- To determine the predictive significance of glutamate elevation in space-occupying ischemic stroke.
- To correlate perfusional disturbances with glutamate alterations in a feline transient ischemia model.
Main Methods:
- Transient middle cerebral artery occlusion (3 hours) followed by reperfusion (6 hours) in anesthetized cats.
- Simultaneous measurement of regional cerebral blood flow (CBF), extracellular amino acids, arterial blood pressure, and intracranial pressure.
- Assessment of CBF using Laser-Doppler flowmetry and positron emission tomography; glutamate levels via microdialysis and HPLC.
Main Results:
- Middle cerebral artery occlusion reduced CBF to <25% of control.
- A 30-fold increase in glutamate was observed during ischemia in 50% of cats, with subsequent recovery.
- A secondary glutamate rise during reperfusion correlated with decreased cerebral perfusion pressure (CPP <60 mm Hg) and herniation.
Conclusions:
- Glutamate levels during ischemia and CPP during reperfusion are predictive of fatal outcomes in malignant focal ischemia.
- Secondary glutamate elevation in reperfusion is associated with critically low CPP (<50 mm Hg) and signs of transtentorial herniation.
- Further glutamate increase may be irrelevant to fatal outcome when CPP drops drastically in late-stage ischemia.